Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-03-18

FDA Approved: CEFEPIME HYDROCHLORIDE AND DEXTROSE — Supplemental Application (B. Braun Medical Inc.)

View source ↗

Summary

FDA approved a supplemental application for Cefepime hydrochloride and dextrose from B. Braun Medical Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CEFEPIME HYDROCHLORIDE AND DEXTROSE (CEFEPIME HYDROCHLORIDE)

Snippet

SUPPL AP for CEFEPIME HYDROCHLORIDE AND DEXTROSE (CEFEPIME HYDROCHLORIDE)